Kopper Chem(834033)

Search documents
康普化学(834033) - 2024 Q4 - 年度财报
2025-03-26 11:45
Financial Performance - The company's operating revenue for 2024 was CNY 330,480,804.78, a decrease of 25.21% compared to CNY 441,870,869.31 in 2023[24]. - The net profit attributable to shareholders for 2024 was CNY 80,299,971.39, down 46.39% from CNY 149,796,746.54 in 2023[24]. - The gross profit margin for 2024 was 43.93%, slightly up from 43.85% in 2023[24]. - The basic earnings per share for 2024 was CNY 0.68, a decline of 46.03% compared to CNY 1.26 in 2023[24]. - The weighted average return on equity based on net profit attributable to shareholders was 11.55% in 2024, down from 24.55% in 2023[24]. - The net profit after deducting non-recurring gains and losses for 2024 was CNY 81,106,444.84, a decrease of 42.30% from CNY 140,557,434.82 in 2023[24]. - The company reported a net cash flow from operating activities of -¥8,922,978.88, a decrease of 109.87% compared to the previous year[26]. - The company's operating profit for 2024 was ¥100,415,963.64, a decline of 42.53% from ¥174,713,370.97 in 2023[68]. - The company's cash and cash equivalents decreased by 215,321,320.26 CNY, a decline of 65.58%, primarily due to payments for investment projects and share repurchases for the employee stock ownership plan[62]. - The company’s other income decreased by 63.63% to ¥2,708,920.71, primarily due to a reduction in government subsidies[71]. Capital and Investment - The company completed a capital increase, raising its total share capital from 91,642,500 shares to 119,135,250 shares[18]. - The company launched a share buyback plan, repurchasing 1,005,000 shares, which is 83.75% of the upper limit of the planned buyback, at a total cost of approximately ¥15.85 million[52]. - The company distributed cash dividends of ¥2 per 10 shares and increased capital by 27,492,750 shares through a stock bonus plan[51]. - The total investment amount for the reporting period was ¥91,469,943.84, a decrease of 31.19% compared to the previous year[87]. - The company has postponed the completion date for the "Annual Production of 20,000 Tons of Special Surfactants" project to March 31, 2024, and the "Kangpu Chemical Technology Research Institute" project to April 10, 2024[146]. Research and Development - The company plans to continue focusing on the development of specialized chemical products, including metal extractants and mineral flotation agents[16]. - The company has established a comprehensive R&D team with over 100 professionals, including 7 PhDs and 31 Masters, to enhance its innovation capabilities[47]. - Research and development expenses increased by 56.30% to ¥17,716,865.88, primarily due to higher salaries for newly hired PhD employees and increased depreciation of buildings and R&D equipment[69]. - R&D expenditure increased to ¥17,716,865.88, representing 5.36% of operating revenue, compared to 2.57% in the previous year[100]. - The company is currently developing a new extraction technology for recycling key battery materials, aiming to significantly reduce production costs and enhance the sustainability of the battery industry[104]. Market and Competition - In 2024, the company experienced a decline in overall operating performance compared to the previous year due to decreased demand from key customers and intensified market competition[46]. - The company is facing increased market competition, particularly in the field of metal extractants, and aims to enhance product layout and R&D investment to maintain a competitive edge[130]. - The company aims to adapt its strategy to meet future growth in emerging markets, particularly in Asia, which accounted for 49% of the global specialty chemicals market in 2022[58]. - The company recognizes the need for continuous technological innovation to maintain competitiveness in the metal extraction and related product markets[127]. Risk Management - There are no significant changes in major risk factors for the current period[9]. - The company faces risks related to customer concentration, with a focus on diversifying its client base to mitigate potential negative impacts on operations[126]. - The company is addressing raw material price volatility by optimizing procurement management and establishing long-term relationships with suppliers[127]. - A comprehensive risk management system will be established to monitor market dynamics, policy changes, and industry competition to mitigate financial and operational risks[180]. Corporate Governance and Compliance - The audit firm Tianjian has issued a standard unqualified audit report for the company's 2024 financial statements, confirming that they fairly reflect the company's financial position and operating results[110]. - The audit committee has approved the reappointment of Tianjian as the company's auditor for the 2024 fiscal year, ensuring compliance with professional qualifications and independence standards[111]. - The company has implemented key internal controls related to revenue recognition to mitigate risks associated with improper revenue reporting[107]. - The company has established a performance-based salary management system to enhance employee motivation and creativity[194]. Social Responsibility and Community Engagement - The company has donated 1 million RMB to the Chongqing Changshou Education Foundation to support local education, reflecting its commitment to social responsibility[115]. - The company is actively involved in rural revitalization efforts, promoting economic development through consumption assistance programs[113]. - The company emphasizes the importance of employee rights and welfare, establishing comprehensive training and promotion systems to support employee growth[115]. Employee and Management Changes - The company has experienced changes in key management positions, including the resignation of the financial officer and the appointment of a new financial officer[188]. - The total salary for directors, supervisors, and senior management in 2024 is set at 3.1302 million yuan[191]. - The company employed a total of 380 employees at the end of the reporting period, an increase of 20 from the beginning of the period[193]. - The number of management personnel increased from 25 to 36, while production personnel decreased from 221 to 200[193].
康普化学:2024年报净利润0.8亿 同比下降46.67%
同花顺财报· 2025-03-26 11:44
Financial Performance - The company's net profit for the year 2024 is 0.8 billion, representing a decrease of 46.67% compared to 1.5 billion in 2023 [1] - Basic earnings per share (EPS) decreased to 0.68 yuan from 1.26 yuan, a decline of 46.03% [1] - Operating revenue fell to 3.3 billion, down 25.34% from 4.42 billion in the previous year [1] - Return on equity (ROE) dropped significantly to 11.55% from 24.55%, a decrease of 52.95% [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 49.37 million shares, accounting for 59% of the circulating shares, with a decrease of 6.11 million shares compared to the previous period [2] - Notable shareholders include Hainan Maishun Investment Partnership with 16.03 million shares (19.16%) and Zou Qian with 11.50 million shares (13.75%), both remaining unchanged [3] - Zou Yang reduced his holdings by 1.19 million shares, while Huang Kunyuan saw a significant decrease of 2.45 million shares [3] Dividend Distribution - There is no specific information provided regarding the dividend distribution plan for the company [4]
康普化学(834033) - 2024年员工持股计划第一次持有人会议决议公告
2025-03-21 11:32
证券代码:834033 证券简称:康普化学 公告编号:2025-016 重庆康普化学工业股份有限公司 2024 年员工持股计划第一次持有人会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记 载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开及出席情况 重庆康普化学工业股份有限公司(以下简称"公司")2024 年员工持股计 划(以下简称"本员工持股计划")第一次持有人会议于 2025 年 3 月 21 日在 重庆市长寿区齐心大道 38 号康普化学技术研究院一楼会议室以现场结合通讯方 式召开。 本次会议由公司董事会秘书兼财务负责人张渝先生召集和主持。本次会议 应出席持有人 44 人,实际出席持有人 41 人,代表本员工持股计划份额 1,011.15 万份,占本员工持股计划总份额的 94.03%。 参与本员工持股计划的董事、监事、高级管理人员已承诺自愿放弃在本员 工持股计划持有人会议的提案权、表决权,并且不担任本员工持股计划管理委 员会任何职务。张冬梅等 3 名董事、监事持有人出席了本次会议但未参与表决, 本次出席但未参与表决的份额合计 ...
康普化学(834033) - 股票解除限售公告
2025-03-17 09:01
证券代码:834033 证券简称:康普化学 公告编号:2025-015 三、本次股票解除限售后的股本情况 重庆康普化学工业股份有限公司股票解除限售公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、本次股票解除限售数量总额为 95,062 股,占公司总股本 0.08%,可交易时 间为 2025 年 3 月 20 日。 二、本次股票解除限售的明细情况及原因 单位:股 | | 股东姓名 | 是否为控 股股东、 实际控制 | 董事、监 | 本次解 限售原 | 本次解除 限售登记 | 本次解除 | 尚未解除 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 事、高级 | | | 限售股数 | | | 序号 | 或名称 | | 管理人员 | | | 占公司总 | 限售的股 | | | | 人或其一 | 任职情况 | 因 | 股票数量 | 股本比例 | 票数量 | | | | 致行动人 | | | | | | | 1 | 刘龙成 | 否 | ...
康普化学:短期业绩承压,长期湿法冶铜替代逻辑不改-20250310
西南证券· 2025-03-10 12:51
Investment Rating - The report assigns a "Hold" investment rating to the company, indicating a cautious outlook for the next six months [29]. Core Insights - The company is experiencing short-term performance pressure due to a decline in demand for copper extraction agents from key customers, alongside rising costs and expenses. However, the long-term logic of wet copper metallurgy replacement remains intact, with expectations for continued growth in copper extraction agent demand driven by global industrialization and the development of new energy industries [6][29]. - The company has made significant progress in launching new products, including new energy metal extraction agents and acid mist suppressants, which are expected to lay a solid foundation for future growth [6][29]. Financial Summary - In 2024, the company is projected to achieve revenue of 330.48 million yuan, a decrease of 25.21% year-on-year, and a net profit attributable to the parent company of 80.17 million yuan, down 46.48% year-on-year [2][6]. - The company's revenue from metal extraction agents is expected to decline by 27.7% in 2024, followed by a recovery of 20% in 2025 and 15% in 2026. The gross margin for metal extraction agents is projected to be 38.0% in 2024, improving to 39.0% by 2026 [26][29]. - The company has a total market capitalization of 25.36 billion yuan and a current share price of 21.29 yuan, with a PE ratio of 32 for 2024 and 24 for 2025 [5][30]. Business Overview - The company is a leading player in the global copper extraction agent market and specializes in the manufacturing of specialty chemicals. It has broken the foreign technology monopoly and is recognized as a domestic leader and internationally known enterprise in this field [7][11]. - The company’s products are primarily used in wet metallurgy, new energy battery metal recycling, and urban mineral resource recycling, with over 90% of its revenue coming from metal extraction agents [16][19]. Market Position - The company has established a strong customer base, including major global mining companies and top-tier enterprises in the new energy sector. Its international sales have been stable, with a significant portion of revenue coming from overseas markets [17][19]. - The company has been recognized for its innovation and has received various honors, including being named a "specialized and innovative" small giant enterprise [7][8].
康普化学(834033) - 关于获批设立国家级博士后科研工作站的公告
2025-03-10 11:46
证券代码:834033 证券简称:康普化学 公告编号:2025-014 特此公告。 重庆康普化学工业股份有限公司 董事会 重庆康普化学工业股份有限公司(以下简称"公司")于近日收到重庆市人 力资源和社会保障局办公室下发的《关于在金凤实验室等 14 个单位设立国家级 博士后科研工作站的通知》(渝人社办〔2025〕23 号),公司获批设立博士后科 研工作站。 公司作为全球特种化学品定制科技服务商,专注于金属萃取技术、矿物浮 选技术、电解电镀酸雾处理技术等的研发,致力于为客户提供定制化产品及服 务方案。本次成功获批设立国家级博士后科研工作站,是对公司技术创新实力、 研发能力和人才培养的肯定,有利于推动公司与高校、科研院所、高端人才等 的合作,为公司引进高层次技术人才、培养和提升科研能力创造条件。 未来,公司将以此为契机,抓紧部署国家级博士后科研工作站的各项工作, 充分发挥平台的资源优势,深化产学研合作,强化研发团队和研发能力的建设, 进一步提升公司技术创新和产品研发能力,为客户提供更优质的服务和解决方 案。 本次获批设立国家级博士后科研工作站,将对公司发展产生积极的促进作 用,不会对公司当期经营业绩产生重大影响,敬 ...
康普化学(834033):短期业绩承压,长期湿法冶铜替代逻辑不改
西南证券· 2025-03-10 07:19
Investment Rating - The report assigns a "Hold" investment rating to the company, indicating a cautious outlook for the next six months [29]. Core Insights - The company experienced a short-term performance pressure due to a decline in demand for copper extraction agents from key customers, alongside increased costs and expenses. However, the long-term logic of wet copper metallurgy replacement remains intact, with expectations for continued growth in copper extraction agent demand driven by global industrialization and the development of new energy industries [6][29]. - The company is recognized as a leading player in the global copper extraction agent market and is actively expanding its product offerings, including new energy metal extraction agents and acid mist suppressants, which have shown positive progress [6][29]. Financial Performance Summary - In 2024, the company is projected to achieve revenue of 330.48 million yuan, a decrease of 25.21% year-on-year, and a net profit attributable to the parent company of 80.17 million yuan, down 46.48% year-on-year [2][6]. - The company's revenue from metal extraction agents is expected to decline by 27.7% in 2024, followed by a recovery of 20% in 2025 and 15% in 2026 [25][26]. - The gross margin for metal extraction agents is projected to be 38.0% in 2024, improving to 39.0% by 2026 [26]. Market Position and Strategy - The company has established itself as a domestic leader and internationally recognized player in the copper extraction agent sector, with a strong focus on R&D and innovation [7][11]. - The company has a concentrated ownership structure, with the chairman holding 38.6% of the shares, which allows for strong decision-making capabilities [8][10]. - The company is actively pursuing international clients while also increasing its domestic market presence, with domestic revenue rising to 65.2% of total revenue in 2023 [17][19]. Future Outlook - The report anticipates that the company's performance will improve as external conditions stabilize and its investment projects begin to yield results, particularly in the context of the growing demand for copper extraction agents driven by the new energy sector [6][29]. - The company is expected to maintain a competitive edge through its focus on technological advancements and product diversification, positioning itself well for future growth [6][29].
康普化学(834033) - 关于签署募集资金三方监管协议之补充协议的公告
2025-03-07 12:16
证券代码:834033 证券简称:康普化学 公告编号:2025-013 重庆康普化学工业股份有限公司 关于签署募集资金三方监管协议之补充协议的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记 载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、募集资金基本情况 重庆康普化学工业股份有限公司(以下简称"公司")于 2022 年 11 月 16 日收到中国证券监督管理委员会出具《关于同意重庆康普化学工业股份有限公 司向不特定合格投资者公开发行股票注册的批复》(证监许可〔2022〕2884 号), 同意公司向不特定合格投资者公开发行股票的注册申请。公司本次发行的发行 价格 14.77 元/股,发行股数 1,500 万股,共计募集资金 22,155.00 万元,坐扣 承销和保荐费用 1,180.62 万元后的募集资金为 20,974.38 万元,已由主承销商 招商证券股份有限公司于 2022 年 12 月 9 日汇入本公司募集资金监管账户。另 减除申报会计师费、律师费、法定信息披露费等与发行权益性证券直接相关的 新增外部费用 703.67 万元和以自有资 ...
康普化学(834033) - 关于2024年员工持股计划完成股票非交易过户的公告
2025-03-06 09:15
证券代码:834033 证券简称:康普化学 公告编号:2025-012 重庆康普化学工业股份有限公司 关于 2024 年员工持股计划完成股票非交易过户的公告 本员工持股计划的股份来源为公司回购专用证券账户回购的公司 A 股普通 股股票。 公司于 2024 年 6 月 21 日召开第四届董事会第二次会议、第四届监事会第 二次会议,审议通过了《关于以集中竞价交易方式回购公司股份的议案》,同 意公司使用自有资金以竞价交易方式回购公司已发行的人民币普通股(A 股) 股票,用于实施员工持股计划或股权激励。 本次回购期限自 2024 年 6 月 21 日开始至 2024 年 9 月 20 日结束,公司通 过回购专用证券账户以集中竞价交易方式回购公司股份 1,005,000 股,占公司 总股本的 0.8436%,占拟回购数量上限的 83.7500%,最高成交价为 17.80 元/股, 最低成交价为 14.20 元/股,已支付总金额为人民币 15,852,178.08 元(不含印 花税、佣金等交易费用)。具体内容详见公司于 2024 年 9 月 23 日在北京证券 交易所信息披露平台(http://www.bse.cn/)披 ...
康普化学(834033) - 2024 Q4 - 年度业绩
2025-02-25 12:55
Financial Performance - The company's operating revenue for 2024 was CNY 330,487,649.85, a decrease of 25.21% compared to the previous year[4] - The total profit for the period was CNY 96,197,200.21, down 44.82% year-on-year[4] - Net profit attributable to shareholders was CNY 80,112,054.48, a decline of 46.52% compared to the same period last year[4] - Basic earnings per share decreased to CNY 0.67, down 46.83% from CNY 1.26 in the previous year[4] Assets and Equity - The total assets at the end of the reporting period were CNY 878,926,932.08, an increase of 3.89% from the beginning of the period[6] - Shareholders' equity attributable to the company was CNY 719,530,508.92, up 7.21% from the beginning of the period[6] Market Challenges and Developments - The company faced challenges due to a decline in demand for copper extraction agents from key customers, impacting overall performance[7] - Increased R&D expenses were incurred due to the recruitment of industry talent to enhance technical capabilities and product competitiveness[7] - The company is currently in the trial production phase of a project to produce 20,000 tons of specialty surfactants, which has not yet generated significant revenue[7] - The company has made progress in expanding the market for new energy metal extraction agents and acid mist suppressants, laying a good foundation for future development[7]